These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36464617)

  • 1. Abdominal sepsis in an immunocompromised patient.
    Yébenes-Calvo R; Díez-Vidal A; Liras-Hernández MG; Civantos-Martín B
    Enferm Infecc Microbiol Clin (Engl Ed); 2023 Apr; 41(4):243-244. PubMed ID: 36464617
    [No Abstract]   [Full Text] [Related]  

  • 2. Bibliography. Infectious diseases. Current world literature.
    Curr Opin Pulm Med; 2012 May; 18(3):279-88. PubMed ID: 22441239
    [No Abstract]   [Full Text] [Related]  

  • 3. Approach to Neurologic Complications in the Immunocompromised Patient.
    Vishnevetsky A; Anand P
    Semin Neurol; 2021 Oct; 41(5):554-571. PubMed ID: 34619781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bibliography. Current world literature. Infections of the immunocompromised host.
    Curr Opin Infect Dis; 2008 Aug; 21(4):445-52. PubMed ID: 18597986
    [No Abstract]   [Full Text] [Related]  

  • 5. Antimicrobial stewardship in immunocompromised hosts.
    Abbo LM; Ariza-Heredia EJ
    Infect Dis Clin North Am; 2014 Jun; 28(2):263-79. PubMed ID: 24857392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sepsis in Immunocompromised Patients Without Human Immunodeficiency Virus.
    McCreery RJ; Florescu DF; Kalil AC
    J Infect Dis; 2020 Jul; 222(Suppl 2):S156-S165. PubMed ID: 32691837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of Mortality in Immunocompromised Children With Severe Sepsis and Septic Shock.
    Lindell RB; Nishisaki A; Weiss SL; Traynor DM; Fitzgerald JC
    Crit Care Med; 2020 Jul; 48(7):1026-1033. PubMed ID: 32301846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma protein C levels in immunocompromised septic patients are significantly lower than immunocompetent septic patients: a prospective cohort study.
    Panwar R; Venkatesh B; Kruger P; Bird R; Gill D; Nunnink L; Dimeski G
    J Hematol Oncol; 2009 Oct; 2():43. PubMed ID: 19840396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Value of Metagenomic Next-Generation Sequencing in Immunocompromised Patients with Sepsis.
    Cheng Z; Yu F
    Med Sci Monit; 2022 Aug; 28():e937041. PubMed ID: 35957507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of a Method to Identify Immunocompromised Patients with Severe Sepsis in Administrative Databases.
    Greenberg JA; Hohmann SF; Hall JB; Kress JP; David MZ
    Ann Am Thorac Soc; 2016 Feb; 13(2):253-8. PubMed ID: 26650336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 late shedding may be infectious between immunocompromised hosts.
    Kaila V; Sirkeoja S; Blomqvist S; Rannikko J; Viskari H; Lyly-Yrjänäinen T; Syrjänen J
    Infect Dis (Lond); 2021 Nov; 53(11):880-882. PubMed ID: 34137349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemorrhagic monkeypox infection in an immunosuppressed patient with human immunodeficiency virus: beyond the pustules.
    Simon-Gozalbo A; Gamo-Guerrero M; Alonso-Garcia S; Mauleon-Fernandez C; Cuevas-Tascon G
    Clin Microbiol Infect; 2023 Jan; 29(1):122-124. PubMed ID: 36206864
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of immunocompromised animals as models for human septic shock.
    Opal SM; Cross AS
    Shock; 2005 Dec; 24 Suppl 1():64-70. PubMed ID: 16374375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A conversation with Janet Englund, MD. Interview by Stanford T. Shulman.
    Englund J
    Pediatr Ann; 2012 Jul; 41(7):296. PubMed ID: 22765042
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prevention of infectious diseases in patients with leukemia].
    Yano K
    Nihon Naika Gakkai Zasshi; 2003 Jun; 92(6):1018-24. PubMed ID: 12866448
    [No Abstract]   [Full Text] [Related]  

  • 16. Albumin replacement therapy in immunocompromised patients with sepsis - Secondary analysis of the ALBIOS trial.
    Cortegiani A; Grasselli G; Meessen J; Moscarelli A; Ippolito M; Turvani F; Bonenti CM; Romagnoli S; Volta CA; Bellani G; Giarratano A; Latini R; Pesenti A; Caironi P
    J Crit Care; 2021 Jun; 63():83-91. PubMed ID: 33636427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sepsis in immunocompromised hosts.
    Conlon C
    J R Coll Physicians Lond; 2000; 34(6):533-6. PubMed ID: 11191968
    [No Abstract]   [Full Text] [Related]  

  • 18. The Reversed Halo Sign: Criteria for Differentiation of Infectious and Noninfectious Diseases.
    Marchiori E; Rodrigues RS; Barreto MM
    AJR Am J Roentgenol; 2019 Dec; 213(6):W295. PubMed ID: 31755759
    [No Abstract]   [Full Text] [Related]  

  • 19. Safe travels! After cancer treatment.
    Kotton CN
    J Travel Med; 2013; 20(2):69-70. PubMed ID: 23464711
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunization of immunocompromised persons.
    Weber DJ; Rutala WA
    Immunol Allergy Clin North Am; 2003 Nov; 23(4):605-34, v-vi. PubMed ID: 14753383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.